7.02

0.43% 0.03

After Hours: 7.02

Angiodynamic Inc (ANGO)

Overview News Price History Option Chain Financials Discussions Forecast

Angiodynamic Inc stock is traded at $7.02, with a volume of 206.55K. It is up +0.43% in the last 24 hours and up +4.31% over the past month. AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.

Previous Close:

$6.99

Open:

$7.05

24h Volume:

206.55K

Relative Volume:

0.44

Market Cap:

$281.53M

Revenue:

$324.01M

Net Income/Loss:

$-192.37M

P/E Ratio:

43.87

EPS:

0.16

Net Cash Flow:

$-23.46M

1W Performance:

+4.15%

1M Performance:

+4.31%

6M Performance:

+13.78%

1Y Performance:

+4.00%

1-Day Range:

$6.98

$7.12

1-Week Range:

$6.71

$7.12

52-Week Range:

$5.26

$8.25

Angiodynamic Inc Stock (ANGO) Company Profile

Name

Angiodynamic Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

(518) 798-1215

Address

14 PLAZA DRIVE, LATHAM

Employee

748

Twitter

@angiodynamics

Next Earnings Date

2024-10-31

Latest SEC Filings

ANGO's Discussions on Twitter

Compare ANGO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ANGO Angiodynamic Inc	7.02	281.53M	324.01M	-192.37M	-23.46M	0.16
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-05-24	Upgrade	Oppenheimer	Perform → Outperform
Sep-25-23	Initiated	H.C. Wainwright	Buy
Apr-17-23	Downgrade	Raymond James	Strong Buy → Outperform
Oct-15-21	Upgrade	Canaccord Genuity	Hold → Buy
Aug-20-21	Initiated	Oppenheimer	Perform
Nov-25-20	Upgrade	Raymond James	Mkt Perform → Strong Buy
Apr-08-20	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Apr-01-19	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Apr-03-18	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-05-18	Downgrade	Craig Hallum	Buy → Hold
Apr-07-17	Reiterated	Cantor Fitzgerald	Overweight
Mar-30-17	Downgrade	KeyBanc Capital Mkts	Overweight → Sector Weight
Feb-08-17	Initiated	Barclays	Equal Weight
Nov-04-16	Initiated	Cantor Fitzgerald	Buy
Apr-08-16	Resumed	Piper Jaffray	Neutral
Jan-08-16	Reiterated	Canaccord Genuity	Buy
Nov-10-15	Downgrade	Raymond James	Outperform → Mkt Perform
Jul-24-15	Initiated	KeyBanc Capital Mkts	Overweight
Jun-19-14	Upgrade	Canaccord Genuity	Hold → Buy
Oct-09-12	Reiterated	Canaccord Genuity	Hold
Jun-25-12	Downgrade	Canaccord Genuity	Buy → Hold
Jul-15-11	Upgrade	Canaccord Genuity	Hold → Buy
Jul-15-11	Upgrade	Stifel Nicolaus	Hold → Buy
Jun-14-11	Downgrade	Wedbush	Neutral → Underperform
Sep-08-10	Reiterated	Wedbush	Neutral

View All

Angiodynamic Inc Stock (ANGO) Latest News

Nov 22, 2024

Segall Bryant & Hamill LLC Has $7.09 Million Stake in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat

Nov 22, 2024

Nov 19, 2024

NeuroOne Medical Technologies (NASDAQ:NMTC) and AngioDynamics (NASDAQ:ANGO) Critical Review - Defense World

Nov 19, 2024

Nov 18, 2024

Royce & Associates LP Has $7.67 Million Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat

Nov 18, 2024

Nov 15, 2024

AngioDynamics, Inc. (NASDAQ:ANGO) Short Interest Update - MarketBeat

Nov 15, 2024

Nov 14, 2024

Wealth Enhancement Advisory Services LLC Buys New Shares in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World

Nov 14, 2024

Nov 12, 2024

AngioDynamics (NASDAQ:ANGO) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Nov 12, 2024

Nov 01, 2024

AngioDynamics Stock Plunges 13.8% in Three Months: What's Next? - MSN

Nov 01, 2024

Oct 30, 2024

AngioDynamics staying in Queensbury after all. Leaders cite changed business model. - The Post Star

Oct 30, 2024

Oct 28, 2024

SG Americas Securities LLC Invests $103,000 in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World

Oct 28, 2024

Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Rises By 31.0% - MarketBeat

Oct 28, 2024

Oct 27, 2024

Cwm LLC Raises Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World

Oct 27, 2024

Oct 26, 2024

Here's Why You Should Add AngioDynamics Stock to Your Portfolio - MSN

Oct 26, 2024

Oct 23, 2024

AngioDynamics (NASDAQ:ANGO) Stock Price Passes Above 200-Day Moving Average – Should You Sell? - Defense World

Oct 23, 2024

Oct 22, 2024

AngioDynamics’ NanoKnife System gains CPT codes for prostate and liver treatments - Medical Device Network

Oct 22, 2024

Oct 21, 2024

AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver - StockTitan

Oct 21, 2024

Oct 16, 2024